Laurus Labs informs about update on acquisition of shares

21 Nov 2023 Evaluate

In continuation of its disclosures dated September 11, 2023 and October 16, 2023 regarding signing of SPAs with the shareholders of Laurus Bio for purchase of 37,641 equity shares through secondary purchase and partial completion of acquisition of 29,308 shares respectively. In this regard, Laurus Labs has informed that the Company has completed the acquisition of balance 8,333 equity shares from the promoter group shareholders of Laurus Bio on November 20, 2023. With this acquisition the Company holds 87.59% shareholding (on fully diluted basis) in Laurus Bio.

The above information is a part of company’s filings submitted to BSE.



Laurus Labs Share Price

570.80 3.65 (0.64%)
26-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1841.50
Dr. Reddys Lab 1355.15
Cipla 1489.20
Lupin 2181.60
Zydus Lifesciences 959.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.